131 related articles for article (PubMed ID: 22281708)
21. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
22. Lethal synergism between influenza virus and Streptococcus pneumoniae.
Müller HE
J Infect Dis; 2003 May; 187(10):1674; author reply 1674-5. PubMed ID: 12721949
[No Abstract] [Full Text] [Related]
23. Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.
Smith BJ; Huyton T; Joosten RP; McKimm-Breschkin JL; Zhang JG; Luo CS; Lou MZ; Labrou NE; Garrett TP
Acta Crystallogr D Biol Crystallogr; 2006 Sep; 62(Pt 9):947-52. PubMed ID: 16929094
[TBL] [Abstract][Full Text] [Related]
24. Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development.
Han N; Ng JTY; Li Y; Mu Y; Huang Z
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781779
[TBL] [Abstract][Full Text] [Related]
25. Neuraminidase activity of influenza virus-infected cells: localization and properties.
Orlova TG; Orlova NG
Acta Virol; 1975 Apr; 19(2):130-6. PubMed ID: 239558
[TBL] [Abstract][Full Text] [Related]
26. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
Yamashita M
Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
[No Abstract] [Full Text] [Related]
27. Influenza Neuraminidase: Underrated Role in Receptor Binding.
Wen F; Wan XF
Trends Microbiol; 2019 Jun; 27(6):477-479. PubMed ID: 30930001
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling of sialyloligosaccharide fragments into the active site of influenza virus N9 neuraminidase.
Veluraja K; Suresh MX; Christlet TH; Rafi ZA
J Biomol Struct Dyn; 2001 Aug; 19(1):33-45. PubMed ID: 11565850
[TBL] [Abstract][Full Text] [Related]
29. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
30. Tethered neuraminidase inhibitors that bind an influenza virus: a first step towards a diagnostic method for influenza.
McKimm-Breschkin JL; Colman PM; Jin B; Krippner GY; McDonald M; Reece PA; Tucker SP; Waddington L; Watson KG; Wu WY
Angew Chem Int Ed Engl; 2003 Jul; 42(27):3118-21. PubMed ID: 12866095
[No Abstract] [Full Text] [Related]
31. Structures of aromatic inhibitors of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
[TBL] [Abstract][Full Text] [Related]
32. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
Wei DQ; Du QS; Sun H; Chou KC
Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
[TBL] [Abstract][Full Text] [Related]
34. [Structure and function of influenza virus neuraminidase].
Itamura S
Nihon Rinsho; 1997 Oct; 55(10):2570-4. PubMed ID: 9360373
[TBL] [Abstract][Full Text] [Related]
35. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Hurt AC; Lowther S; Middleton D; Barr IG
Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
[TBL] [Abstract][Full Text] [Related]
36. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.
Varghese JN; Colman PM; van Donkelaar A; Blick TJ; Sahasrabudhe A; McKimm-Breschkin JL
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11808-12. PubMed ID: 9342319
[TBL] [Abstract][Full Text] [Related]
37. Tailor made sialidase inhibitors home in on influenza virus.
Corfield T
Glycobiology; 1993 Oct; 3(5):413-5. PubMed ID: 8286849
[No Abstract] [Full Text] [Related]
38. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
[TBL] [Abstract][Full Text] [Related]
40. Analysis of inhibitor binding in influenza virus neuraminidase.
Smith BJ; Colman PM; Von Itzstein M; Danylec B; Varghese JN
Protein Sci; 2001 Apr; 10(4):689-96. PubMed ID: 11274459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
